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1  | INTRODUC TION AND SCOPE OF THE 
CONFERENCE
Subsequent	to	the	discovery	that	loss-	of-	function	mutations	in	kis-
speptin signalling genes cause reproductive deficits in humans and 
mice,1-4	 the	field	of	kisspeptin	 (KISS1)	 research	has	exploded.	Two	
previous	international	meetings	were	held	on	kisspeptin	biology,	in	
2008	and	2012,	as	a	forum	for	capturing	that	progress,	sharing	new	
data and facilitating collaboration. Both earlier meetings focused 






the	brain	and	beyond,	 including	peripheral	 tissues	such	as	 the	go-
nads,	liver	and	placenta.
The	 avalanche	of	 research	on	kisspeptin	over	 the	past	decade	
and	 a	 half	 has	 demonstrated	 the	 quintessential	 role	 of	 kisspeptin	
neurones	 in	 awakening	 pulsatile	 GnRH	 secretion	 at	 puberty	 and	







and	 calcium-	imaging	 technologies,	 we	 stand	 at	 the	 threshold	 of	




nents	 of	 the	 kisspeptin-	GnRH	 pulse	 generating	mechanisms,5,6 as 
well	as	the	inter-	and	intracellular	signalling	pathways	that	mediate	
physiological and developmental control of reproduction92;	 (ii)	 the	
mechanisms by which peripheral and metabolic cues gate pubertal 
activation	of	kisspeptin	and	GnRH	neurones;	and	(iii)	the	role	of	kis-
speptin neurones in mediating the influence of other internal and 






development	and	sperm	motility,10-14 although we have only begun to 
scratch	the	surface	of	this	new	realm	of	KISS1	biology.	Other	recent	
studies	have	implicated	hepatocyte-	derived	KISS1	in	the	regulation	

















meeting was rated as a success by attendees and covered a wide range of lively and 
provocative	discussion	topics	on	the	changing	nature	of	the	field	of	“kisspeptinology”	
and its future.
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new	ideas	about	the	role	of	kisspeptin	signalling	in	the	regulation	of	
metabolism and body weight regulation.16	Kisspeptin	may	play	a	role	




about this placental dialogue and its possible implications for placen-
tal	physiology	and	disorders,	such	as	pre-	eclampsia.21
As	 noted	 above,	 a	 pressing	 frontier	 of	 knowledge	 in	 this	 field	
is	 an	understanding	of	 the	 translation	of	 basic	 knowledge	of	 kiss-
peptin	 and	 related	 peptides	 to	 the	 treatment	 of	 disease.	As	 such,	
it is important to consider both reproductive and nonreproductive 
aspects	of	KISS1	biology,	 such	as	with	 respect	 to	pharmacothera-
peutics	 related	 to	 kisspeptin,	 NKB,	 and	 dynorphin	 signalling	 for	
treatment	 of	 infertility,	 polycystic	 ovary	 syndrome	 (PCOS)	 and	
other disorders.22-25	 Indeed,	the	discovery	of	the	role	of	NKB	as	a	





of	 kisspeptin	 in	 the	 central	 and	peripheral	 control	 of	body	weight	
and	metabolism,15,16,86	 the	possibility	exists	 for	 future	 therapeutic	






in	 the	 field.	As	 noted	 above,	We	 also	 considered	 the	present	 and	









who	were	asked	 to	 identify	 the	 “big	questions”	 that	 remain	 in	our	
field.	Based	on	this	survey,	issues	and	areas	were	selected	as	topics	
for	 large	and	small	group	sessions.	 In	addition,	the	meeting	format	
was purposely designed to promote informal interaction and discus-













2  | MA JOR UNRESOLVED QUESTIONS, 
CONTROVERSIES AND RESE ARCH 
DIREC TIONS FOR THE FUTURE
As	noted	in	the	Introduction,	a	major	aim	of	the	conference	was	to	
stimulate open and speculative discussions of unresolved major is-
sues	related	to	the	emerging	functional	roles	of	kisspeptin,	 includ-
ing current obstacles and challenges to future progress and eventual 
clinical/translational impact.
The following are synopses of the discussions held in each of the 
facilitated	large	group	sessions,	reflecting	those	areas	identified	by	
the	pre-	meeting	interest	survey.	Other	topics	concerning	unresolved	
questions	 and	 future	 directions	 were	 the	 subject	 of	 the	 informal	
lunch table discussions held on each day of the conference. These 
smaller table discussions were just as fruitful as the large group 
sessions.	The	individual	topics	and	questions	addressed	during	the	
luncheons	are	listed	in	the	scientific	program	(see	Supporting	infor-
mation,	Figure	S2)	but	due	 to	space	 limitations,	 they	are	not	sum-
marised here.
2.1 | How do kisspeptin neurones participate in the 
gating of puberty?
Over	a	decade	ago,	Science	magazine	 identified	“what	 triggers	pu-
berty?”	as	1	of	125	questions	needing	an	answer.94 This was 2 years 
after	the	discovery	of	kisspeptin	as	a	major	excitatory	neuromodula-
tor of reproductive neuroendocrine function. Over the intervening 
period,	arcuate	kisspeptin	neurones	have	been	postulated	to	medi-




differences in the tempo of puberty and pubertal disorders are a 
result	of	kisspeptin	sex	differences,	and	what	turns	on	kisspeptin	at	




may	 involve	 later	 development	 of	 arcuate	 kisspeptin	 (KNDy)	 neu-
rones in males.87	 Precisely	 which	 attributes	 of	 KNDy	 neurones	
are	 critical	 remains	 a	 point	 of	 debate,	with	 signs	 pointing	 to	NKB	
in	 some	 species	 and	 kisspeptin	 in	 others.	 This	 suggests	 that	NKB	
and	 kisspeptin	may	 act	 as	 independent	 signals	 at	 different	 stages	
of	 reproductive	 neuroendocrine	 development.	 Some	 of	 these	 dif-
ferences	 may	 arise	 from	 the	 mechanisms	 of	 oestradiol	 feedback,	
which in itself is still controversial as a basis for prepubertal restraint 
of	GnRH	neurone	output.	Does	oestradiol	merely	regulate	expres-
sion	 of	 neuromodulators	 and,	 if	 so,	 how	 (eg,	 epigenetic	 changes)?	
















opening or still in the process because oestrous cyclicity and fer-
tility	are	not	established?	Another	area	of	discussion	was	whether	
or	not	there	are	neuronal	circuits	upstream	of	kisspeptin	neurones	
(eg,	 glutamatergic,	GABAergic,	 Tac1,	 substance	P)	 that	 participate	





Although	 the	 field	 has	 made	 progress,	 the	 question	 posed	 in	
Science	12	years	ago	(“what	forces	childhood	to	end?”)	remains	un-











ages in children to optimise therapeutic interventions?




and differences of it in rodents and ruminants.28	Two	speakers	pre-
sented	evidence	 in	mice	that	optogenetic	 inhibition	of	KNDy	neu-
rones	 in	vivo	 inhibited	episodic	 luteinising	hormone	 (LH)	secretion	
and	that	optogenetic	stimulation	of	KNDy	neurones	in	a	slice	prep-
aration stimulated this population in the contralateral arcuate and 
induced	a	circuit-	wide	excitation	via	an	NKB-	driven	slow	excitatory	
postsynaptic	potential	(EPSP).	The	third	presentation	demonstrated	












human32	 revealed	 either	 few	or	 no	 dynorphin	 cell	 bodies,	 despite	
previous	reports	of	dynorphin	mRNA	within	the	area.33 The inability 
to	detect	dynorphin	colocalisation	with	kisspeptin	or	NKB	cells	was	
considered	a	challenge	to	the	translational	value	of	the	KNDy	neu-




the ewe34	 and	 goat,35 pharmacological and electrophysiological 
studies in rodents have not supported the proposed role of endog-




Additional	 future	 directions	 discussed	 in	 this	 forum	 included	
investigation	 of	 non-	KNDy	 neurones	 that	 could	 contribute	 to	 the	
control	of	GnRH/LH	pulse	generation,	such	as	kisspeptin	neurones	
of the medial amygdala. The continued investigation of the mecha-
nistic	basis	of	GnRH/LH	pulse	generation	will	use	exciting	new	tools	
in neuroscience that can correlate the activity of isolated neuronal 
circuits	with	GnRH	and	LH	release,	such	as	optogenetics,	fast-	scan	
cyclic voltammetry and calcium imaging.84
2.3 | Negative- feedback and hormone regulation of 
arcuate (ARC) kisspeptin cells
Based	on	observations	of	brain	region-	specific	regulation	of	kisspep-
tin	mRNA	and	peptide	in	response	to	gonadal	steroids,41 one of the 













Several	 major	 obstacles	 were	 identified	 as	 challenges	 to	 an-
swering	questions	related	to	the	role	of	ARC	kisspeptin	neurones	in	




nonclassical	 oestrogen	 receptor	 in	 mediating	 oestrogen	 negative-	
feedback.	 Current	 controversies	 discussed	 include	 the	 issue	 of	
possible species difference in the role of dynorphin in oestrogen 




research were discussed in this session. This included recent electro-
physiological findings42 showing that oestradiol decreases glutama-
tergic	inputs	to	ARC	kisspeptin	neurones,	and	also	that	glutamatergic	
transmission to the same cells is increased in female mice bearing 
kisspeptin-	specific	knockout	of	oestrogen	receptor	α. Perhaps most 
exciting	was	evidence	indicating	that	serial	LH	pulse	bleeds	in	kiss-
peptin-	ER	knockout	mice	showed	significant	impairment	in	oestro-





2.4 | Positive- feedback and hormone control of 
preoptic kisspeptin neurones
Ovulation in female mammals is gated at the neuroendocrine level 
by	an	oestrogen-	mediated	positive-	feedback	induction	of	LH	secre-
tion.	 This	 “surge”	 release	 of	 LH	 is	 itself	 controlled	 by	 a	 preceding	
surge in GnRH secretion from the brain. The secretion of GnRH is 
itself tightly regulated by a collection of hormones and upstream 












neurones	 is	 required	 to	 mount	 an	 LH	 surge	 using	 an	 oestradiol-	
positive-	feedback	model,43,44 suggesting these neurones integrate 
both oestradiol and progesterone steroid signalling to generate the 
surge.


































AVPV/PeN	 population	 and,	 if	 so,	 do	 these	 sub-	populations	 serve	
different	physiological	processes?	Continued	in	vivo	work	using	ad-




2.5 | How do kisspeptin neurones participate 
in the regulation of body temperature, stress and 
other nonreproductive functions?
This	session	addressed	the	issue	of	how	kisspeptin	neurones	par-
ticipate	 in	 the	 regulation	 of	 body	 temperature	 and	 stress	 and,	
more	broadly,	how	kisspeptin	neurones	participate	in	the	control	
of autonomic functions. Because reproduction is a fundamental 
homeostatic	 function,	 it	 is	 possible	 that	 a	 set	 of	 central	 “com-
mand”	 neurones	 coordinates	 all	 of	 these	 other	 functions	 with	
reproduction.	 Therefore,	 this	 session	 covered	 diverse	 functions,	
such	 as	 temperature,	 circadian	 rhythms,	 parturition,	 lactation,	





ARC	 kisspeptin	 (KNDy)	 neurones	 in	 the	 steroidal	 regulation	 of	
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body	temperature.	Because	all	3	KNDy	peptides	are	increased	in	
the	postmenopausal	state,	it	has	been	postulated	that	NKB	trans-
mission	may	play	 a	 role	 in	hot	 flushes.	 Indeed,	basic	 findings	on	
the	critical	 role	of	KNDy	neurones	and	their	NKB	projections	 to	
the medial preoptic area in the control of body temperature90 set 
the	stage	for	exciting	clinical	trials	for	treating	hot	flushes	in	post-
menopausal	women	with	NKB	 receptor	 (NK3R)	 antagonists.83	 A	
point	of	discussion	was	where	exactly	at	the	cellular	level	are	the	
NK3R	 antagonists	 acting	 to	 block	 KNDy	 neuronal	 transmission:	
presynaptically or postsynaptically?
Other	talks	in	this	session	highlighted	the	role	of	arcuate	KISS1	
neurones in the regulation of circadian rhythms and nonrapid eye 





rect actions on suprachiasmatic neurones. Evidence was also pre-
sented	 for	 a	 role	 of	AVPV/PeN	kisspeptin	 neurones	 in	 parturition	









KISS1R	 and	 NPFFR1	 antagonists)	 to	 appropriately	 and	 rigorously	
parse	out	this	pathway.	Finally,	interesting	findings	were	presented	
on	the	role	of	kisspeptin	in	mediating	social	behaviour	in	the	medaka 
fish.	 A	 kisspeptin	 homologue	 activates	 KISS1R	 in	 neuropeptide	 B	
neurones	 that	 synapse	 on	 and	 excite	 vasotocin/isotocin	 neurones	
in	this	species,	regulating	social	behaviours	associated	with	mating.
The overarching theme throughout this session was the observa-
tion	that	kisspeptin	neurones	are	very	complex	with	respect	to	the	
neurotransmitters	that	they	express,	how	they	are	regulated	during	
different	 physiological	 states,	 and	 the	 projections/synapses	 that	






receptors and/or are the peptide and amino acid neurotransmitters 
differentially	released	at	different	firing	frequencies	as	earlier	find-
ings40	would	suggest?	Key	to	addressing	these	and	other	challenges	
is	 the	need	for	better	pharmacological	 tools	 (peptide	agonists	and	
antagonists)	 to	 parse	 out	 specific	 functions.	 Cellular	 physiologi-
cal studies will help to establish the efficacy and selectivity of ag-
onists and antagonists such that they can be moved forward into 
whole	animal	experiments	and	ultimately	 into	 the	clinic.	Certainly,	
the	current	ongoing	development	of	NKB	antagonists	for	treatment	
of postmenopausal hot flushes is a strong proof of concept for this 
approach.83
2.6 | What are the reproductive functions of 
kisspeptin/KISS1R systems in the periphery?
Although	 KISS1	 and	 KISS1R	 are	 expressed	 widely	 outside	 of	 the	
brain,	 the	 roles	 of	 KISS1R	 signalling	 in	 the	 periphery	 remain	 rela-
tively	 poorly	 understood.	 KISS1	 and/or	 KISS1R	 are	 expressed	 in	
reproductive	 tissues	 such	 as	 the	 ovary,	 testes,	 endometrium	 and	
the	placenta,53	 leading	 to	 the	hypotheses	 that	KISS1R	signalling	 is	
involved in the local regulation of reproduction within these tissues. 
This session featured presentations and discussions that focused on 
the	roles	of	the	kisspeptin	signalling	system	in	these	tissues.
The	use	of	genetically-	modified	mice	has	revealed	potential	roles	
for	 KISS1/KISS1R	 signalling	 in	 ovarian	 and	 endometrial	 function,	
with	a	 loss	of	KISS1R	signalling	causing	defects	in	ovarian	reserve,	
implantation	 and	 pregnancy.	 Whether	 or	 not	 these	 findings	 are	
relevant	 to	human	disorders	of	 reproduction	 is	 an	 important,	out-
standing	question.	It	was	reported	that	a	woman	bearing	a	mutation	
in	the	KISS1R,54	who	had	a	failed	pregnancy,	was	 later	able	to	be-
come pregnant following in vitro fertilisation treatment and carry 
the	pregnancy	to	term.	Whether	the	mutation	resulted	in	a	complete	
loss-	of-	function55 or may be associated with spontaneous reversal 
of infertility56	was	not	 resolved.	A	published	study57 further high-
lighted	species	differences	by	revealing	that	kisspeptin,	although	de-
tectable in very high levels in the blood during pregnancy in humans 
and	some	primates,	 is	barely	detectable	 in	other	species.	The	 role	
of	circulating	kisspeptin	in	humans	and	the	reason	for	 its	potential	
absence in other species remains to be clarified.
The	 ability	 to	 study	 the	 role	 of	KISS1/KISS1R	 signalling	 in	 the	
periphery	remains	difficult	and	further	research,	particularly	in	hu-
mans,	is	required.	A	recently	developed	mouse	model	lacking	periph-
eral signalling but retaining intact central signalling85 has served as 
a powerful tool for investigating the peripheral roles for the ovarian 
and	 endometrial	 KISS1/KISS1R	 in	 regulating	 fertility.20	 However,	
many	 questions	 remain,	 including	 whether	 circulating	 kisspeptin	
originates	from	the	placenta,	the	liver15 or elsewhere; does it regu-
late placental function and/or the timing of parturition; and can its 
levels	be	used	as	a	biomarker	for	pre-	eclampsia	risk?	Furthermore,	if	
circulating	kisspeptin	is	important	for	pregnancy,	is	there	a	compen-
satory	mechanism	 in	 the	 absence	of	KISS1R	 signalling	 in	 humans?	
These	important	questions	must	be	addressed	as	progress	is	made	
to	 better	 understand	 the	 reproductive	 functions	 of	 kisspeptin/
KISS1R	systems	in	the	periphery.
2.7 | Metabolic functions of kisspeptin 
in the periphery
There is an obvious connection between gonadal function and 
metabolism,	 via	 multiple	 convergent	 regulatory	 pathways,	 acting	
in the brain and peripheral tissues.58	Although	 evidence	 indicates	
that	 metabolic	 signals	 can	 influence,	 directly	 or	 indirectly,	 KISS1	
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However,	 the	 nature	 and	 physiological	 relevance	 of	 such	 di-
rect	 metabolic	 actions	 of	 kisspeptins	 are	 yet	 to	 be	 fully	 defined	
and	are	 still	 a	matter	of	 considerable	debate.	Although	 the	 initial	
results	failed	to	document	any	detectable	effects	of	kisspeptin	on	
food	 intake,59	 more	 recent	 data	 showed	 that	 congenital,	 whole	
body	 absence	 of	 kisspeptin	 signalling	 increased	 body	weight	 and	
adiposity,	as	well	as	glucose	 intolerance,	 in	 female	mice,	 irrespec-
tive of gonadal status.16 This would suggest there us a primary 
role	 of	 kisspeptin	 signalling	 in	 body	weight/glucose	 homeostasis,	
whose	underpinnings	remain	unclear.	Intriguingly,	KISS1R	null	mice	
eat	less,	pointing	out	potential	alterations	in	the	thermogenic	pro-
gram	 that	 need	 to	 be	 investigated	 to	 explain	 the	 conundrum	 of	




lin  production.15 Dysregulation of such a circuit has been suggested 
to	 be	 causative	 for	 hyperglycaemia	 and	 type-	2	 diabetes.	 Yet,	 no	
conclusive evidence for dysregulated glycaemia has emerged so far 
from	pharmacological	studies	addressing	the	 impact	of	kisspeptin	
administration	 to	 laboratory	 animals	 and	 humans,	 and	 data	 for	
stimulatory	 rather	 than	 inhibitory	 effects	 of	 kisspeptin	on	 	insulin	
secretion,60	depending	on	prevailing	glucose	concentrations,	have	





pects	 of	 adipocyte	 biology,	 such	 as	 differentiation,	 thermogenic	
programing and potential secretory activity.
Given	 the	 gaps	 in	 the	 existing	 evidence,	 additional	 efforts	 are	
needed	to	fully	clarify	the	metabolic	roles	of	kisspeptin,	teasing	apart	
its genuine direct effects from the potential secondary actions as a 
result	of	its	capacity	to	modulate	gonadal	steroid	secretion.	Similarly,	
the	actual	impact	and	pathophysiological	relevance	of	kisspeptin	not	




the control of thermogenesis or adipocyte biology warrant further 
investigation.	All	these	efforts	will	allow	us	to	elucidate	the	putative	
metabolic	 dimension	 of	 kisspeptin,	 its	 eventual	 physiological	 rele-
vance and possible therapeutic implications.
2.8 | What are the challenges and likely 
outcomes of drug development in the field?
Basic	 and	 translational	 research	 has	 identified	 kisspeptin	 and	 the	
neurokinins	 as	 key	 regulators	 of	 various	 aspects	 of	 reproductive	
physiology and pathology.63-65	 In	 parallel	 to	 this,	 several	 agonists	
and	 antagonists	 for	 both	 kisspeptin	 and	NKB	 receptors	 are	under	




peptides in both physiological and pathophysiological states. 
These	include	both	common	disorders	such	as	PCOS,67 as well as 
more rare conditions such as idiopathic hypogonadotrophic hypo-
gonadism.68 Human studies often generate greater impact when 
they are able to draw upon observations made in animal mod-
els.69-71	 These	 complex	 and	 time-	consuming	mechanistic	 studies	
are	 critical	 for	 ensuring	 appropriate	 and	 evidence-	based	 clinical	
applications.




may prove to be fundamental to their efficacy for treating hot flushes 
and	PCOS.25,72,73	In	addition,	recent	data	suggests	that	different	for-
mulations	of	 kisspeptin	 have	different	 capabilities	with	 respect	 to	
crossing the BBB when administered peripherally.74 Probing these 
considerations is not only important in understanding the biology 
of these neuropeptides but also will be relevant when considering 
which	form	of	kisspeptin	to	use	in	a	clinical	setting.
Third,	 clinical	 trial	 protocols	 should	 be	developed	 in	 reflection	
of important unmet clinical needs while at the same time balancing 
the	unique	requirements	of	vulnerable	populations	such	as	adoles-
cents75 and pregnant women.76	Clear,	well-	defined	end-	points,	bet-
ter	assay	tools	and	a	thorough	understanding	of	off-	target	effects	
will	be	essential.	In	addition,	appropriate	doses	and	routes	of	admin-
istration need to be determined for the current and future arsenal of 
agonists,	antagonists	and	mixed	agonists-	antagonists.77
Finally,	advancing	fundamental	basic	and	translational	research	
to	 produce	 meaningful	 clinical	 impact	 requires	 the	 development	
of fruitful partnerships between academia and the pharmaceutical 
industry.	 Academic	 organisations	 and	 pharmaceutical	 companies	
often	have	different	 expectations	 for	drug	development,	with	dif-
ficulties encountered in technology transfer and carrying out trials 
for	“off	the	shelf”	compounds.	Furthermore,	these	difficulties	vary	
from	 country	 to	 country.	 However,	 with	 potentially	 exciting	 new	
diagnostic	and	treatment	options	for	a	variety	of	disorders,	includ-
ing	idiopathic	hypogonadotrophic	hypogonadism,68,78 hypothalamic 
amenorrhoea,79	 hyperprolactinaemia,80	 	infertility,22 menopausal 
hot	 flushes,73	 psychosexual	 disorders81,82	 and	 PCOS25 already on 
the	horizon,	overcoming	the	challenges	in	drug	development	for	the	
kisspeptin	field	is	an	important	and	worthy	goal.
2.9 | What are the biggest technical and conceptual 
impediments or concerns to progress in the field?
The	role	of	kisspeptin-	KISS1R	signalling	in	regulating	and	maintaining	
reproductive	function	is	well	established.	However,	many	obstacles	
8 of 13  |     LEHMAN Et AL.
exist	regarding	the	optimal	approach	for	studying	the	mechanisms	
and	physiological	 impact	of	kisspeptin	signalling	at	the	level	of	the	
brain and in the periphery.
Important	questions	regarding	kisspeptin	neurocircuitry	remain	
to	be	answered	to	move	the	field	forward.	Although	hypothalamic	
kisspeptin	 neurones	 are	 well	 established	 as	 being	 intricately	 in-
volved with the regulation of GnRH neurones and gonadotrophin re-
lease,	pinpointing	the	exact	nuclei	(AVPV,	PeN	and	ARC)	responsible	

















is	 epitope-	tagged	 (eg,	 HA	 or	 FLAG)	 could	 enable	 the	 localisation,	
tracking	and	interactions	of	KISS1R	within	cells	to	be	examined	in	a	
variety of tissues.
Improved	assays	 for	measuring	kisspeptin	output	and	 its	 func-
tional	 effects	 on	 various	 organ	 systems	 are	 also	 needed.	 Several	
kisspeptin-	secreting	 cell	 lines	 have	 recently	 become	 available	 and	
will enable assessment of mechanistic interactions between recep-
tors	and	second	messenger	cascades	within	the	kisspeptin	cell.	The	













Recently,	 the	 emergence	 of	 single-	cell	 RNA	 sequencing	 has	
provided the most direct and unbiased method for definng a cell 
type	 based	 on	 its	 transcriptional	 profile,	which	 can	 provide	 ad-
ditional insights into connectivity and function of the cell. This 
method	can	facilitate	the	discovery	of	gene	expression	profile	of	
Kiss1	 neurones,	 identifying	 the	 repertoire	 of	 surface	 receptors	
that may mediate physiological responses.91,92 This approach 
can help provide tremendous insights into upstream signals 
that	 converge	 on	 Kiss1	 neurones	 to	modulate	 the	 reproductive	
axis.	 Furthermore,	 an	 advanced	 approach	 for	 translational	 pro-
filing of neurones based on connectivity using viral translating 
ribosome affinity purification has been reported recently.93 In 
this	 approach,	 CRE-	dependent	 adeno-	associated	 virus	 or	 other	
retrograde	 viruses	 (rabies	 or	 canine	 adenovirus)	 are	 engineered	
to	 express	 an	 enhanced	 green	 fluorescent	 protein-	tagged	 ribo-
some	 protein	 enabling	 rapid	 access	 to	 translating	 mRNAs	 from	
a	discrete	CRE-	expressing	neural	population.	Projection-	specific	
translational profiling is achieved by selectively precipitating neu-
ronal	ribosomes	based	on	connectivity.	A	quantitative	polymerase	
chain	 reaction	 is	 then	 used	 for	 selected	 target	 genes	 or	 high-	
throughput	RNA	sequencing	 to	determine	 the	neuronal	 identity	
without the need for detailed anatomical or electrophysiological 
investigation.93
Much	 has	 been	 achieved	 in	 the	 kisspeptin	 field.	 The	 ongoing	
revolutions	 in	 techniques	will	 enable	 the	 detailed	 investigation	 of	
defined	populations	of	cells	and	their	interactions	at	both	network	
and	whole	organism	levels	to	continue	to	produce	exciting	insights.	
The application of these methodologies will provide unprecedented 
opportunities	to	advance	kisspeptin	research	and	generate	a	com-
prehensive	 understanding	 of	 physiology	 of	 kisspeptin	 signalling	
throughout the body.





in the 2 morning poster sessions. Over 120 of the attendees par-
ticipated in the small group lunch table discussions on each of the 
2 days.
To	assess	 the	effectiveness	of	 the	meeting	and	 its	 format	 (see	






survey respondents were either satisfied or very satisfied with the 




of comments and specific suggestions for improvements: a number 
of participants suggested increasing the length of short presenta-
tions	 in	 the	 facilitated	group	 sessions	 to	5	minutes	each,	 blending	
in longer presentations as needed at the same time as maintaining 
time	for	questions	and	discussion.	In	general,	attendees	were	enthu-
siastic	about	the	different	type	of	meeting	structure,	and	comments	
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included	“amazing	format”,	“format	very	informative	and	productive”	




looking	 view	 of	 a	 scientific	 field	 that	 is	 continuing	 to	 evolve	 in	
both	 scientific	 scope	 and	 range	of	 impact.	 The	 interactive,	 non-
traditional meeting format was well received and facilitated the 
informal	 exchange	 of	 new	 data	 and	 ideas,	 interactions	 between	
researchers	at	varying	career	stages,	and	open	discussion	of	 the	
challenges and obstacles to be overcome for the field to move for-
ward. The participation of researchers from a number of pharma-






have never been greater and the coming years are certain to be 
exciting	ones.
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APPENDIX 1
Kisspeptin 2017: a different kind of scientific meeting
Planning for this conference grew out of informal discussions among 




and that sufficient new information had been developed since 2012 





from around the world to determine whether there was sufficient 
interest	in	another	meeting.	After	email	exchanges,	the	general	con-
sensus	was	to	hold	a	2-	day	meeting	as	a	satellite	conference	with	the	
2017	 meeting	 of	 the	 Endocrine	 Society	 (ENDO2017)	 in	 Orlando,	
Florida,	 to	 minimise	 travel	 costs	 and	 maximise	 participation.	
Organizing	and	Program	Committees	were	quickly	formed	(for	mem-
bership	 list,	 see	 the	 Supporting	 information,	 Figure	 S1),	 with	 Dr	
Michael	Lehman	serving	as	the	meeting	organiser	and	chair	of	the	2	
committees.















the control of reproduction into other important physiological sys-
tems.	The	intent	was	to	take	the	opportunity	to	ripen	and	harvest	the	
fruits of this new research — morphing the field from a focus on one 

















reversed the usual placement of poster sessions at the end of the 
day	and,	 instead,	started	each	day	with	a	poster	session/breakfast	
grouped	around	specific	topics	related	to	the	scientific	questions	to	
be featured later at lunch discussions and general sessions. Our goal 
was to use poster sessions to encourage people to share with others 







•	 What	 are	 the	 most	 important	 contemporary	 questions	 in	 the	
realm	of	kisspeptin	biology?
•	 What	are	 the	biggest	 impediments	 (technically	or	otherwise)	 to	
answering	these	questions?
•	 What	 are	 the	 biggest	 controversies/debates/disagreements	 re-
lated	to	kisspeptin	biology?
Based	 on	 the	 responses	 received,	 the	 Organizing	 and	 Program	
Committees	identified	major	areas	of	interest	for	lunch	table	and	large	
group discussions and began to shape the overall structure of the sci-
entific	program	(see	Supporting	information,	Figure	S2).
On	the	first	day	of	the	meeting,	there	was	a	short	welcome	ses-
sion that included a general orientation to the meeting format and 
process.	Then,	as	mentioned,	the	morning	of	each	day	was	taken	up	









informal	 networking	 for	 trainees	 attending	 the	 meeting	 (also	 see	
Career	Development	activities	below).
Afternoon	 sessions	 consisted	 of	 large	 group	 facilitated	 discus-
sions for all attendees that were focused on the major unresolved 
questions,	 issues	 and	 controversies	 identified	 in	 the	 pre-	meeting	
questionnaire	(see	Supporting	information,	Figure	S2).	Sessions	ran	
in	series,	rather	than	in	parallel,	so	that	the	entire	group	could	attend	
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issues	to	be	discussed.	The	facilitator	also	served	as	moderator,	help-
ing	 to	move	 presentations	 and	 discussions	 along,	 and	 ensure	 that	
multiple	points	of	view	were	expressed	 freely	and	openly.	A	 large	
group	 session	 at	 the	 end	 of	 the	meeting	 reviewed	 the	 highlights,	
consensus	 items,	and	discussed	open	questions,	opportunities	and	
next	steps.	Social	events	were	held	on	each	evening,	aiming	to	fur-




during the meeting to encourage and support the professional ca-
reer	development	of	early-	stage	investigators	and	trainees.	With	the	
support of a scientific conference grant from the National Institutes 






reer	 track	 experience	 that	matched	 the	 individual	 trainee’s	 career	
goals,	with	the	aim	of	providing	trainees	with	networking	opportuni-
ties.	A	breakfast	event	for	mentor-	mentee	meetings	was	held	on	the	




settings. These activities were held before the poster sessions so 
that there was no conflict with the remainder of the scientific pro-
gram.	Activities	were	mandatory	 for	 travel	 awardees,	 although	 all	
other trainees attending the meeting were welcomed and encour-
aged	to	participate.	Participation	in	these	events	was	very	high,	re-
flecting the high value with which they were viewed by trainees and 
early-	stage	investigators.
